- Release Date: 14/11/24 08:34
- Summary: Positive Data from Phase II Trial in Soft Tissue Sarcoma
- Price Sensitive: Yes
- Download Document 262.09KB
- Forums
- ASX - By Stock
- IMM
- Ann: Positive Data from Phase II Trial in Soft Tissue Sarcoma
IMM
immutep limited
Add to My Watchlist
0.00%
!
26.0¢

Ann: Positive Data from Phase II Trial in Soft Tissue Sarcoma
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
26.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $381.6M |
Open | High | Low | Value | Volume |
26.0¢ | 26.5¢ | 25.5¢ | $189.7K | 731.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 37999 | 26.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
27.0¢ | 67000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 37999 | 0.260 |
5 | 406295 | 0.255 |
17 | 401705 | 0.250 |
10 | 368315 | 0.245 |
24 | 4967216 | 0.240 |
Price($) | Vol. | No. |
---|---|---|
0.270 | 67000 | 2 |
0.275 | 158787 | 6 |
0.280 | 273037 | 9 |
0.285 | 110080 | 5 |
0.290 | 124500 | 4 |
Last trade - 16.10pm 04/08/2025 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
AFP
AFT PHARMACEUTICALS LIMITED
Hartley Atkinson, CEO & Founder
Hartley Atkinson
CEO & Founder
Previous Video
Next Video
SPONSORED BY The Market Online